Reckitt Benckiser Group PLC (RKT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Reckitt Benckiser Group PLC (RKT) has a cash flow conversion efficiency ratio of 0.191x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX1.49 Billion ≈ $180.68K USD) by net assets (GBX7.78 Billion ≈ $946.72K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Reckitt Benckiser Group PLC defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Reckitt Benckiser Group PLC - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Reckitt Benckiser Group PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Reckitt Benckiser Group PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Reckitt Benckiser Group PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shandong Minhe Animal Husbandry Co Ltd
SHE:002234
|
0.026x |
|
Hotel Majestic Cannes
PA:MLHMC
|
0.033x |
|
Lontrue Co Ltd
SHE:300175
|
-0.111x |
|
Autolus Therapeutics plc
F:6A3A
|
-0.378x |
|
Haleon PLC
LSE:HLN
|
0.032x |
|
Viking Line Abp
HE:VIK1V
|
0.151x |
|
Southern States Bancshares Inc
NASDAQ:SSBK
|
0.033x |
|
Shandong Sinobioway Biomedicine Co Ltd
SHE:002581
|
-0.043x |
Annual Cash Flow Conversion Efficiency for Reckitt Benckiser Group PLC (2002–2025)
The table below shows the annual cash flow conversion efficiency of Reckitt Benckiser Group PLC from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see Reckitt Benckiser Group PLC stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | GBX7.78 Billion ≈ $946.72K |
GBX2.30 Billion ≈ $279.48K |
0.295x | -26.03% |
| 2024-12-31 | GBX6.72 Billion ≈ $817.63K |
GBX2.68 Billion ≈ $326.32K |
0.399x | +28.23% |
| 2023-12-31 | GBX8.47 Billion ≈ $1.03 Million |
GBX2.64 Billion ≈ $320.72K |
0.311x | +23.14% |
| 2022-12-31 | GBX9.48 Billion ≈ $1.15 Million |
GBX2.40 Billion ≈ $291.65K |
0.253x | +11.01% |
| 2021-12-31 | GBX7.45 Billion ≈ $906.81K |
GBX1.70 Billion ≈ $206.48K |
0.228x | -40.72% |
| 2020-12-31 | GBX9.16 Billion ≈ $1.11 Million |
GBX3.52 Billion ≈ $428.04K |
0.384x | +156.08% |
| 2019-12-31 | GBX9.41 Billion ≈ $1.14 Million |
GBX1.41 Billion ≈ $171.68K |
0.150x | -9.61% |
| 2018-12-31 | GBX14.79 Billion ≈ $1.80 Million |
GBX2.45 Billion ≈ $298.58K |
0.166x | -9.59% |
| 2017-12-31 | GBX13.57 Billion ≈ $1.65 Million |
GBX2.49 Billion ≈ $303.08K |
0.184x | -36.15% |
| 2016-12-31 | GBX8.43 Billion ≈ $1.03 Million |
GBX2.42 Billion ≈ $294.69K |
0.287x | +11.27% |
| 2015-12-31 | GBX6.91 Billion ≈ $840.26K |
GBX1.78 Billion ≈ $217.06K |
0.258x | -15.89% |
| 2014-12-31 | GBX6.83 Billion ≈ $831.50K |
GBX2.10 Billion ≈ $255.39K |
0.307x | -8.25% |
| 2013-12-31 | GBX6.34 Billion ≈ $770.91K |
GBX2.12 Billion ≈ $258.06K |
0.335x | +5.00% |
| 2012-12-31 | GBX5.92 Billion ≈ $720.54K |
GBX1.89 Billion ≈ $229.71K |
0.319x | +7.28% |
| 2011-12-31 | GBX5.78 Billion ≈ $703.38K |
GBX1.72 Billion ≈ $209.03K |
0.297x | -0.03% |
| 2010-12-31 | GBX5.13 Billion ≈ $624.17K |
GBX1.52 Billion ≈ $185.55K |
0.297x | -38.14% |
| 2009-12-31 | GBX4.01 Billion ≈ $488.39K |
GBX1.93 Billion ≈ $234.70K |
0.481x | +21.58% |
| 2008-12-31 | GBX3.29 Billion ≈ $400.78K |
GBX1.30 Billion ≈ $158.42K |
0.395x | -1.08% |
| 2007-12-31 | GBX2.38 Billion ≈ $290.19K |
GBX953.00 Million ≈ $115.95K |
0.400x | -26.68% |
| 2006-12-31 | GBX1.87 Billion ≈ $227.04K |
GBX1.02 Billion ≈ $123.74K |
0.545x | +30.86% |
| 2005-12-31 | GBX1.86 Billion ≈ $225.82K |
GBX773.00 Million ≈ $94.05K |
0.416x | -5.32% |
| 2004-12-31 | GBX1.58 Billion ≈ $192.24K |
GBX695.00 Million ≈ $84.56K |
0.440x | +23.26% |
| 2003-12-31 | GBX1.47 Billion ≈ $179.34K |
GBX526.00 Million ≈ $64.00K |
0.357x | -1.80% |
| 2002-12-31 | GBX1.21 Billion ≈ $146.98K |
GBX439.00 Million ≈ $53.41K |
0.363x | -- |
About Reckitt Benckiser Group PLC
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil a… Read more